China Home Healthcare Market Analysis Report [2022-30] I Insights10

China Home Healthcare Market Analysis

$ 3999

The China home healthcare market was valued at $29.15 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $59.94 Bn in 2030. One of the main reasons propelling the growth of this market is the rising number of the elderly population and changing lifestyles. The market is segmented by equipment outlook and by services. Some key players in this market are WeDoctor, AliHealth, Haodaifu, JD Health, and iKang Healthcare Group Guahao.

ID: IN10CNHS010 CATEGORY: Healthcare Services GEOGRAPHY: China AUTHOR: Nandini Shah

Buy Now

China Home Healthcare Market Executive Summary

The China home healthcare market was valued at $29.15 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $59.94 Bn in 2030. Home visits, home care, and home sickbeds are three different sorts of services that are offered by community health service centers, public hospitals, and private medical institutions in China's cities of Beijing, Shanghai, Shenzhen, and Jinan, among others. Regarding service delivery, service receivers, and payment options, these medical facilities vary.

In China, the healthcare industry has grown significantly in both revenue and employment. Hospitals, medical equipment, pharmaceutical products, and services including clinical trials, telemedicine, e-health, health tourism, home healthcare, and health insurance are all included in the definition of healthcare. The extension of services increased coverage, and rising governmental and private investment in the healthcare industry in China have all contributed to the sector's growth.

In 2020 the National Health Commission and the National Administration of Traditional Chinese Medicine urged for the expansion of home-based healthcare services for the elderly as well as for the precise matching of their varied urgent medical service requirements. However, China's home healthcare services are still in their experimental stage and face a number of difficulties compared to the nations in Europe, the United States, Japan, and many other nations.

china home healthcare market analysis

Market Dynamics

Market Growth Drivers

The home healthcare industry in China is a rapidly growing market due to an aging population and increasing demand for healthcare services. The Chinese government has been making efforts to promote the development of the home healthcare industry in recent years, and there are several factors driving its growth: China has an aging population, and the number of elderly people requiring home healthcare services is increasing. Also, the Chinese government has been actively promoting the development of the home healthcare industry and has implemented policies to increase funding and support for the industry. The increasing prevalence of chronic diseases such as diabetes and hypertension is driving the demand for home healthcare services. The introduction of new technologies such as telemedicine and remote monitoring devices is making home healthcare more accessible and efficient. The growing middle class in China is increasing the demand for home healthcare services as they are more able to afford and access them. Urbanization has led to an increase in elderly people living alone and the need for home healthcare services.

Market Restraints

The home healthcare industry in China is facing a lack of professional healthcare staff, a lack of regulation and standardization, and limited reimbursement for home healthcare services. The Chinese government is working on addressing these challenges and implementing policies and regulations to promote the development of the home healthcare industry. They aim to improve the quality and accessibility of home healthcare services and to make them more affordable for the general population.

Competitive Landscape

Key Players

Ping An Good Doctor
WeDoctor
AliHealth
Haodaifu
JD Health
iKang Healthcare Group
Guahao

Healthcare Policies and Regulatory Landscape

China's healthcare policy prioritizes universal access to basic medical services and aims to provide affordable healthcare for all citizens. The government has implemented a number of initiatives to improve healthcare delivery, including increasing investment in rural healthcare and expanding health insurance coverage. These include:

The "Healthy China 2020" initiative, focuses on improving access to basic medical services and promoting the development of home healthcare services.
The "13th Five-Year Plan" for Health Development, includes a number of measures to promote home healthcare, such as the development of home healthcare service networks and the training of home healthcare workers.
The "Regulations on the Administration of Medical Devices," stipulate that medical devices used in home healthcare must be registered and certified by the National Medical Products Administration (NMPA) before they can be marketed in China.
The "Guiding Opinions on the Development of Home Medical Services" sets out the general direction for the development of home medical services, including the establishment of a unified and standardized home medical service system, and the improvement of the legal and regulatory environment for the home medical service industry.

Overall, the Chinese government is actively promoting the development of home healthcare services as a way to improve access to healthcare and reduce the burden on hospitals. The regulatory policies and guidelines have been established to improve the quality of home healthcare services and ensure.

Reimbursement scnerio

In terms of drug reimbursement, China's medical insurance system was first implemented in 1998 and has since been gradually expanded to include the majority of the Chinese people. Individual members in the national medical insurance scheme, as well as their employers (if any), must contribute to the medical insurance funds by paying a monthly insurance premium. Participants in medical insurance programmes are eligible for full or partial payment of the cost of medicines included in the NRDL, which includes over 2,000 Western and Chinese medicines classified as Class A and Class B drugs. Class A pharmaceuticals are typically low-cost and clinically required drugs that can be fully reimbursed, but Class B drugs are frequently higher-priced or novel drugs that need patients to bear 10-40% of the entire cost.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Home Healthcare Market Segmentation

By Device Type (Revenue, USD Billion):

Based on the Device Type the market is segmented into Testing, Screening, Monitoring Devices, Therapeutic Home Healthcare Devices, and Mobility Assist.

Testing, Screening, and Monitoring Device
Blood Glucose Monitors
Blood Glucose Monitors
Blood Pressure Monitors
Heart Rate Monitors
Temperature Monitors
Sleep Apnea Monitors
Coagulation Monitors
Ovulation and Pregnancy Test Kits
Pulse Oximeters
Home Hemoglobin A1C Test Kit

Therapeutic Home Healthcare Devices
Oxygen Delivery Systems
Nebulizers
Ventilators
Sleep Apnea Therapeutic Devices
Wound Care Products
IV Equipment
Dialysis Equipment
Insulin Delivery Devices
Inhalers
?Other Therapeutic Products (ostomy devices, automated external defibrillators (AEDs)

Mobility Assist
Walkers and Rollators
Wheelchairs
Canes
Crutches
?Mobility Scooters

By Service Type (Revenue, USD Billion):

Skilled Nursing Services
Rehabilitation Therapy Services
Hospice and Palliative Care Services
Unskilled Care Services
Respiratory Therapy Services
Infusion Therapy Services
Pregnancy Care Services?

By Indication Type (Revenue, USD Billion):

Cardiovascular Disorders & Hypertension
Diabetes
Respiratory Diseases
Pregnancy
Mobility Disorders
Hearing Disorders
Cancer
Wound Care
?Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.